Sunkyung Kim

Dr. Sunkyung Kim


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2014 in Journal of Child Neurology
Verified
Journal Article
Closed access
PDF file
SKSunkyung Kim
Sunkyung Kim
KCKimberly A. Campbell
Kimberly A. Campbell
DFDeborah J. Fox
Deborah J. Fox
DMDennis J. Matthews
Dennis J. Matthews
RVRodolfo Valdez
Rodolfo Valdez
TSThe Md Starnet
The Md Starnet
This population-based study examines the association between corticosteroid treatment and time to loss of ambulation, stratifying by treatment duration (short: 0.25-3 years, long: >3 years), among 477 Duchenne muscular dystrophy cases identified by the Muscular Dystrophy Surveillance Tracking and Research Network (MDSTARnet). Those cases who received short-term corticosteroid treatment had a time to loss of ambulation that was 0.8 years shorter (t test) and an annual risk of losing ambulation 77% higher than the untreated (Cox regression). Conversely, cases who received long-term corticosteroid treatment had a time to loss of ambulation that was 2 years longer and an annual risk of losing ambulation 82% lower than the untreated, up to age 11 years; after which the risks were not statistically different. The relationship of corticosteroids and time to loss of ambulation is more complex than depicted by previous studies limited to treatment responders or subjects who lost ambulation during study follow-up.

1 August 2015 in Archives of Physical Medicine and Rehabilitation
Verified
Journal Article
Closed access
SKSunkyung Kim
Sunkyung Kim
EWElisabeth Ward
Elisabeth Ward
BDBrad E. Dicianno
Brad E. Dicianno
GCGerald H. Clayton
Gerald H. Clayton
KSKathleen J. Sawin
Kathleen J. Sawin
JCJames Chinarian
James Chinarian

1 August 2017 in Neuromuscular Disorders
Verified
Journal Article
Closed access
SKSunkyung Kim
Sunkyung Kim
YZYong Zhu
Yong Zhu
PRPaul A. Romitti
Paul A. Romitti
DFDeborah J. Fox
Deborah J. Fox
DSDaniel W. Sheehan
Daniel W. Sheehan
BBBrent J. Barber
Brent J. Barber

25 November 2016 in Journal of Public Health Dentistry
Verified
Journal Article
Closed access
PDF file
SKSunkyung Kim
Sunkyung Kim
SPSohyun Park
Sohyun Park
MLMei Lin
Mei Lin

7 February 2018 in BMC Public Health
Verified
Journal Article
Open access
PDF file
LMLindsey S. McCrickard
Lindsey S. McCrickard
SCStacy M. Crim
Stacy M. Crim
SKSunkyung Kim
Sunkyung Kim
ABAnna Bowen
Anna Bowen
Shigella causes approximately 500,000 illnesses, 6000 hospitalizations, and 40 deaths in the United States annually, but incidence and populations at risk for severe shigellosis among adults are unclear. This study describes severe shigellosis among US adults. We analyzed Foodborne Diseases Active Surveillance Network data for infections caused by Shigella among adults ≥18 years old during 2002–2014. Criteria to define severe shigellosis included hospitalization, bacteremia, or death. We estimated annual incidence of shigellosis per 100,000 among adult populations, and conducted multivariable mixed-effects logistic regression to assess associations between severe shigellosis, demographic factors and Shigella species among adults with shigellosis. Among 9968 shigellosis cases, 2764 (28%) were severe. Restricting to cases due to S. sonnei and S. flexneri, median annual incidence of severe shigellosis among adults was 0.56 and highest overall incidence was among black males 18–49 years old (1.58). Among adults with shigellosis, odds of severe disease were higher among males than females aged 18–49 years old (OR [95% CI] = 1.32 [1.15–1.52], p < 0.001) and among males than females with S. flexneri infections (OR [95% CI] =1.39 [1.10–1.75], p = 0.005). The odds of severe shigellosis were higher among blacks than whites (OR [95% CI] = 1.36 [1.22–1.52], p < 0.001). Among adults, men 18–49 years old, particularly blacks, have the highest incidence of severe shigellosis. Among adults with shigellosis, severe shigellosis was associated with being male in age group 18–49 years, with infections caused by S. flexneri, and with black race. Future research should assess associations between severe shigellosis and sexual practices, antimicrobial resistance, comorbidities, and access to care.

1 March 2015 in Obesity Research & Clinical Practice
Verified
Journal Article
Closed access
SKSunkyung Kim
Sunkyung Kim
RVRodolfo Valdez
Rodolfo Valdez